Literature DB >> 120993

An experimental approach to the study of intraocular Toxocara canis.

M N Luxenberg.   

Abstract

An experimental study of nematode endophthalmitis due to T canis and review of the literature has been presented. Six owl monkeys were infected either by nasogastric tube using embryonated T canis eggs or by carotid or intravitreal injection of second stage larvae. The clinical manifestations, especially ocular, were observed and various diagnostic tests performed. Only minimal or no intraocular changes were seen after systemic infection but significant abnormalities such as retinal hemorrhages and venous dilation were noted after intravitreal infection. Motile larvae were observed in the lenses of three eyes and in the vitreous of five eyes and, probably a sixth, after intravitreal injection. The intensity and timing of the intraocular reaction seemed to correlate with the infecting dose and apparent disappearance of larvae from the eye. Pathologic confirmation of larvae in the lens was obtained in one eye. A marked inflammatory reaction occurred in eyes receiving intraocular infection but none was seen in eyes with only systemic infectin. Various laboratory and serologic studies were performed, including the ELISA test, which were used to evaluate systemic as well as intraocular responses to infection with T canis. The two monkeys infected by nasogastric tube gave a positive ELISA response in the serum but intraocular fluids gave a negative response in all monkeys including those infected syst:mically and/or intraocularly. Problems in the understanding of clinical aspects of the disease, laboratory diagnosis and treatment are discussed. The need for future experimental studies is emphasized.

Entities:  

Mesh:

Year:  1979        PMID: 120993      PMCID: PMC1311717     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  78 in total

1.  Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes.

Authors:  E Engvall; K Jonsson; P Perlmann
Journal:  Biochim Biophys Acta       Date:  1971-12-28

2.  Asymptomatic urethral gonorrhoea in men.

Authors:  P M Perera; K Sim Lim
Journal:  Br Med J       Date:  1975-08-16

3.  In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigen for use in serodiagnostic tests for visceral larva migrans.

Authors:  D H Savigny
Journal:  J Parasitol       Date:  1975-08       Impact factor: 1.276

4.  Nematode endophthalmitis.

Authors:  W H BENEDICT
Journal:  J Tn State Med Assoc       Date:  1958-08

5.  Observations on the development of Toxocara canis (Werner, 1782) in the dog.

Authors:  J F SPRENT
Journal:  Parasitology       Date:  1958-05       Impact factor: 3.234

6.  A contribution to the life history and larval morphology of Toxocara canis.

Authors:  J F SCHACHER
Journal:  J Parasitol       Date:  1957-12       Impact factor: 1.276

7.  The etiology of visceral larva migrans. I. Diagnostic morphology of infective second-stage Toxocara larvae.

Authors:  R L NICHOLS
Journal:  J Parasitol       Date:  1956-08       Impact factor: 1.276

8.  Larva migrans.

Authors:  P C BEAVER
Journal:  Exp Parasitol       Date:  1956-11       Impact factor: 2.011

9.  Visceral larva migrans; with a case report.

Authors:  J H DENT; R L NICHOLS; P C BEAVER; G M CARRERA; R J STAGGERS
Journal:  Am J Pathol       Date:  1956 Jul-Aug       Impact factor: 4.307

10.  Ocular toxocariasis in mice: distribution of larvae and lesions.

Authors:  L J Olson
Journal:  Int J Parasitol       Date:  1976-06       Impact factor: 3.981

View more
  2 in total

1.  Prevalence of Toxocara canis in babies and in adults as determined by the ELISA test.

Authors:  J Berrocal
Journal:  Trans Am Ophthalmol Soc       Date:  1980

2.  New animal model for human ocular toxocariasis: ophthalmoscopic observation.

Authors:  T H Takayanagi; N Akao; R Suzuki; M Tomoda; S Tsukidate; K Fujita
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.